1. Effect of Synbiotic Supplementation in a Very‐Low‐Calorie Ketogenic Diet on Weight Loss Achievement and Gut Microbiota: A Randomized Controlled Pilot Study
- Author
-
Francisco J. Tinahones, Jose Manuel García-Almeida, Gracia María Martín-Núñez, Isabel Moreno-Indias, Carolina Gutiérrez-Repiso, Juan Alcaide-Torres, Lidia Sánchez-Alcoholado, Diego Bellido, Ignacio Sajoux, and Carmen Hernandez-Garcia
- Subjects
Adult ,Male ,0301 basic medicine ,Synbiotics ,medicine.medical_treatment ,Microbial diversity ,Physiology ,Pilot Projects ,Gut flora ,Placebo ,Placebos ,Feces ,03 medical and health sciences ,Weight loss ,Weight Loss ,Humans ,Medicine ,Single-Blind Method ,Obesity ,Caloric Restriction ,Inflammation ,030109 nutrition & dietetics ,Anthropometry ,Bacteria ,biology ,business.industry ,Low calorie ,Middle Aged ,biology.organism_classification ,Gastrointestinal Microbiome ,Bifidobacterium animalis ,030104 developmental biology ,Dietary Supplements ,Female ,medicine.symptom ,Diet, Ketogenic ,business ,Food Science ,Biotechnology ,Ketogenic diet - Abstract
Scope Little is known about the changes that a very-low-calorie ketogenic diet (VLCKD) produces in gut microbiota or the effect of synbiotics during the diet. The aim of this study is to evaluate changes in gut microbiota produced by a VLCKD and synbiotic supplementation. Methods and results A randomized, single-blind, parallel-design trial is conducted in 33 obese patients who follow a weight-loss program (PnK-Method) that include a VLCKD followed by a low-calorie diet (LCD). Subjects are randomly allocated to three groups: one supplemented with synbiotics, a second group supplemented with a placebo during the VLCKD and synbiotics during the LCD phase, and a control group given a placebo. Although symbiotic administration do not produce an effect on microbial diversity, an increase in short-chain fatty aciding producing bacteria and anti-inflammatory mediator signals such as Odoribacter and Lachnospira is shown. The administration of Bifidobacterium animalis subsp. lactis and prebiotics fiber during the LCD is significantly associated with the percentage of weight loss and change in glucose, C-reactive protein and lipopolysaccharide-binding protein. Conclusions VLCKD produces important changes in gut microbiota. The administration of synbiotics during VLCKD can improve weight loss through the amelioration of inflammation, which may be mediated by the gut microbiota.
- Published
- 2019
- Full Text
- View/download PDF